| Literature DB >> 21753858 |
Kazuhisa Hasui1, Jia Wang, Xinshan Jia, Masashi Tanaka, Taku Nagai, Takami Matsuyama, Yoshito Eizuru.
Abstract
This study investigated autophagy in 37 cases of nasopharyngeal lymphomas including 23 nasal natural killer (NK)/T-cell lymphomas (NKTCL), 3 cytotoxic T-cell lymphomas (cytotoxic-TML) and 9 B-cell lymphomas (BML) by means of antigen-retrieval immunohistochemistry of beclin-1, LC3, mitochondria (AE-1) and cathepsin D. Peculiar necrosis was noted in EBV(+) lymphomas comprising 21 NKTCL, 2 cytotoxic-TML and 1 BML. Lymphomas without peculiar necrosis showed high expression of beclin-1, macrogranular cytoplasmal stain of LC3 with sporadic nuclear stain, a hallmark of autophagic cell death (ACD), some aggregated mitochondria and high expression of cathepsin D, suggesting a state of growth with enhanced autophagy with sporadic ACD. EBV(+) NKTCL with the peculiar necrosis, showed significantly low level of macrogranular staining of LC3, aggregated mitochondria and low expression of cathepsin D in the cellular areas when degenerative lymphoma cells showed decreased beclin-1, significantly advanced LC3-labeled autophagy, residual aggregated mitochondria and significantly reduced expression of cathepsin D, suggesting advanced autophagy with regional ACD. Consequently it was suggested that enhanced autophagy and reduced expression of lysosomal enzymes induced regional ACD under EBV infection in NKTCL.Entities:
Keywords: Epstein-Barr virus (EBV); LC3; NKT-cell lymphoma nasal type; antigen retrieval immunohistochemistry (beclin-1; autophagic cell death; autophagy; mitochondria (AE-1) and cathepsin D); nasopharyngeal lymphoma
Year: 2011 PMID: 21753858 PMCID: PMC3130144 DOI: 10.1267/ahc.10024
Source DB: PubMed Journal: Acta Histochem Cytochem ISSN: 0044-5991 Impact factor: 1.938
Clinicopathological information and status of Epstein-Barr virus infection in the cases examined
| Age (yrs) | Site (EBV infection status; EBV−:EBV+/−:EBV+) | |||||||
|---|---|---|---|---|---|---|---|---|
| No. | M/F | |||||||
| Mean | Range | Nasal cavity | Pharynx | Unknown | ||||
| T/NK-cell neoplasm (TML) | 28 | 19:9 | 44.5 | 18–70 | 19 (2:0:17) | 6 (0:2:5) | 3 (0:0:3) | |
| NK/T-cell lymphoma (NKTCL) | 23 | 17:6 | 43.0 | 20–56 | 17 (2:0:15) | 3 (0:0:3) | 3 (0:0:3) | |
| Cytotoxic T-cell lymphoma (Cytotoxic TML) | 3 | 2:1 | 47.3 | 18–67 | 1 (0:0:1) | 2 (0:1:1) | 0 | |
| Polymorphous reticulosis (PR)/Early NKTCL (E-NKTCL) | 2 | 0:2 | 57.0 | 29, 65 | 1 (0:0:1) | 1 (0:1:0) | 0 | |
| B-cell neoplasm (BML) | 9 | 3:6 | 52.4 | 13–84 | 3 (0:0:3) | 5 (3:2:0) | 1 (0:1:0) | |
So-called nasal NKTCL comprises NKTCL, Cytotoxic TML and PR/E-NKTCL.
EBV infection status: EBV−: no infection in lymphoma cells; EBV+/−: incomplete neoplastic expansion of EBV latent infection in lymphoma cells; EBV+: complete neoplastic expansion of EBV latent infection in lymphoma cells.
Antibodies used and antigen retrieval/detection methods
| Antibody | Specificity or function | Clone/Source | Dilution | Antigen retrieval | Detection method |
|---|---|---|---|---|---|
| CD3ε | T cells, NK/T cells | NCL-CD3-PS1/Vision Biosystems | 1:100 | Heat* | Polymer |
| CD5 | T cells | NCL-CD5-4C7/Vision Biosystems | 1:50 | Heat* | Polymer |
| CD79a | B cells | M7050/Dako | 1:200 | Heat* | Polymer |
| TIA1 | T cells, NK/T cells (Cytotoxic granules) | TIA1/Coulter Immunology | 1:500 | Heat* | Polymer |
| CD56 | NK/T cells, plasma cells | NCL-CD56-IB6/Vision Biosystems | 1:50 | Heat* | Polymer |
| Cleaved caspase-3 | Irreversible apoptosis | 5A1 Asp175/Cell Signaling Co. | 1:200 | Heat** | Polymer |
| Survivin | Inhibitor of apoptosis | ab469/Abcam | 1:500 | Heat** | Polymer |
| Beclin-1 | Autophagic vesicle nucleation | Sc-11427/Santa Cruz | 1:50 | Enzyme | Supersensitive |
| LC-3 | Autophagic vesicle elongation | PM036/MBL | 1:1000 | Heat** | Polymer |
| AE-1 | Mitochondria | AE-1/Leinco Technologie Inc. | 1:50 | Heat** | Polymer |
| Cathepsin D | Lysosomal enzyme | NCL-CDm (C5)/Vision Biosystems | 1:100 | Heat** | Polymer |
Antigen retrieval methods: Heat*; Sections were heated in citrate buffer pH 6 (Target retrieval solution, S1699, Dako) for 5 min at 121°C in an autoclave. Heat**; Sections in the citrate buffer (Diva Decloaker, Biocare Medical) for 5 min at 121°C in an autoclave. Enzymatic antigen retrieval; Sections were treated with 200 mg/mL proteinase K Tris buffer saline solution for 10 min at room temperature.
Detection methods: Polymer; ChemMate Envision system (K5027, Dako). Supersensitive; The polymer method (K5027, Dako) with blocking of non-specific reactions, the catalyzed reporter deposition (CARD) reaction and its detection in a catalyzed signal amplification (CSA) system with blocking diffused deposition in CARD reaction.
Fig. 1Detection of EBV latent infection by means of ISH of EBER-1. The long axis of all microphotographs was 215 µm long at ×40 magnification. Lymphomas without EBV latent infection (EBV−, a, d) show no or rare probably small memory B-cells infected latently by EBV. Lymphomas with EBV latent infection (EBV+, c, f) show EBER-1 signals in the most lymphoma cells, suggesting complete neoplastic expansion of EBV latent infection. Lymphomas show EBER-1 signals in a few to some lymphoma cells (EBV+/−, b, e), suggesting incomplete neoplastic expansion of EBV latent infection.
The positive and negative control in IHC of apoptosis and autophagy-related molecules employed in this study
| Antibody | Positive control for IHC of each antigen in ordinary human pathology specimens | Negative control for IHC of each antigen in ordinary human pathology specimens | Ref. no. |
|---|---|---|---|
| Cleaved caspase-3 | Apoptotic cells. | Cells other than apoptotic cells. | 15 |
| *Positive cells were the apoptotic cells in human gastric foveolar surface epithelia. | *Negative cells were human gastric foveolar surface epithelia other than apoptotic cells labeled by cleaved caspase-3. | ||
| Survivin | Human malignant neoplastic (cancer and lymphoma) cells and stem cells. | Normal human cells other than malignant neoplastic, stem and fetal cells. | 32 |
| *Positive cells were nasopharyngeal lymphoma cells, squamous carcinoma cells and squamous epithelial (tissue) stem cells. | *Negative cells were squamous epithelia other than squamous epithelial (tissue) stem cells of which nuclei were densely labeled by survivin. | ||
| Beclin-1 | Almost all living cells. | None. | 15, 32 |
| *Positive cells were some gastric fundic glandular cells, a few gastric glandular cells having possibly mutated beclin-1 accumulated in nuclei in the gastric fundic mucosa inflamed with | *Negative cells were the human gastric glandular cells in the gastric fundic mucosa inflamed with | ||
| LC3 | Almost all living cells. | None. | 32 |
| *Positive cells: almost all cells in human lymph node with necrotizing lymphadenitis and nasopharyngeal lymphoma tissue cells. | *Degenerated lymphoma cells among autophagic cell death labeled densely by LC3 gradually diminished the immunostaining of LC3 and could be the inner negative control. | ||
| AE-1 | Almost all living cells. | None | — |
| *Some macrophages showed large granular immunostaining of AE-1 and could be the inner positive control. | *Small lymphocytes were negative and could be the inner negative control. | ||
| Cathepsin D | Almost all living cells | None | — |
| *Some macrophage showed dense immunostaining of cathepsin D and could be the inner positive control. | *Small lymphocytes were negative and could be the inner negative control. | ||
*: In IHC employed in this study.
Fig. 2Cellular, degenerative and necrotic areas in lymphoma tissue. The long axis of all the microphotographs was 215 µm long at ×40 magnification. The peculiar necrosis in NKTCL is seen as the ill-defined areas comprising naked nucleus-like cell debris and coagulated, acidophilic, and necrotic cells (b, d), and can be differentiated from the necrotic lesions in microinfarction revealing microthrombus in and around the necrotic areas (f, h). The degenerative areas in lymphoma tissue (D) are defined as the areas next to the necrotic areas (N). Cellular (C), degenerative (D) and necrotic areas (N) in the lymphoma tissue can be easily differentiated each other. Note that lymphoma cells show more adhesive growth in the cellular areas than in the degenerative ones.
Scoring system in IHC of beclin-1, LC3, mitochondria (AE-1), and cathepsin D
| Score | Definition | Sample image* | |
|---|---|---|---|
| Beclin-1 | 0 | No staining | Fig. 4 a2, a5, |
| 1 | Weak staining | Fig. 4 a4, Fig. | |
| 2 | Moderate staining | Fig. 4 a3, Fig. | |
| 3 | Strong staining | Fig. 4 a1 | |
| 4 | Very strong staining | — | |
| LC3 | 0 | No staining | — |
| 1 | Microgranular staining in cytoplasm | — | |
| 2 | Macrogranular staining in background of strong microgranular staining in cytoplasm | Fig. 4 b1, b3Fig. 5 b1, b3 | |
| 3 | Macrogranular staining in background of decreased microgranular staining in cytoplasm | Fig. 4 b2, b4, | |
| 4 | Nuclear or perinuclear dense staining in background of Score 2 or 3 | Fig. 4 b5, Fig. | |
| 5 | Nuclear or perinuclear dense staining without the background of Score 2 and 3 | — | |
| Mitochondria (AE-1) | 0 | No aggregated mitochondria | — |
| 1 | Aggregated mitochondria in a few neoplastic cells | Fig. 4 c5, | |
| 2 | Aggregated mitochondria in some neoplastic cells | Fig. 4 c1, c3, Fig. | |
| 3 | Aggregated mitochondria in many neoplastic cells | Fig. 4 c2, c4Fig. 5 c2, c3, c4 | |
| Cathepsin D | 0 | No staining in neoplastic cells | Fig. 4 d5, Fig. |
| 1 | Weak staining in neoplastic cells | Fig. 4 d3, | |
| 2 | Moderate staining in neoplastic cells | Fig. 4 d1, d4, Fig. | |
| 3 | Strong staining in neoplastic cells | Fig. 4 d2 | |
Sample image*: Sample images (×100 oil magnification) of each score of each staining in Figures 4 and 5 were indicated when evaluation of the immunostaining was carried out on the recorded images at ×40 magnification for reproducibility. Score 4 immunostaining of beclin-1 was possibly detected also by the polymer method. Scores 4 and 5 immunostaining of LC3 were of ACD when the background staining diminished as residual LC3 molecules in acidophilic cell debris were gradually depleted. IHC of mitochondria (AE-1) employed detected aggregated mitochondria but not scattered mitochondria in cytoplasm such as those in small lymphocytes. Immunostaining of cathepsin D in lymphoma cells was graded when intermingling macrophages showed very strong staining.
Fig. 3A representative nasal NK/T-cell lymphoma (NKTCL). The long axis of all the microphotographs was 215 µm long at ×40 magnification. a to f: cellular areas. g to i: degenerative and necrotic areas. a and g: hematoxylin-eosin staining. NKTCL cells in the cellular areas (a) are positive for TIA1 (b) and CD56 (c) and show signals of EBER-1 ISH (d). Rare cleaved caspase-3-positive lymphoma cells were observed in cellular areas (e) and in degenerative and necrotic areas (h). The NKTCL cells expressed survivin (f and i). Necrosis in NKTCL was not due to apoptosis suppressed by neoplastic expression of survivin.
Autophagy-related molecules and organella in nasopharyngeal lymphomas in representative cellular areas free from degeneration and necrosis
| Mean score evaluated value (S. D.) in IHC | ||||||
|---|---|---|---|---|---|---|
| EBV | N | |||||
| Beclin-1 | LC3 | Mitochondria (AE-1) | Cathepsin D | |||
| TML | 28 | 2.0 (1.2) | 2.6 (1.0) | 2.3 (0.9) | 1.1 (0.9) | |
| NKTCL | − | 2 | 3.0 (1.4) | 3.0 (1.4) | 1.0 (1.4) | 1.0 (1.4) |
| NKTCL | + | 21 | 2.1 (1.2) | 2.5 (0.9) | 2.6 (0.7) | 0.9 (0.9)#1,2 |
| Cytotoxic-TML | +/− or + | 3 | 1.0 (1.0) | 3.0 (1.0) | 2.0 (1.0) | 2.0 (—)#1,2 |
| E-NKTCL | +/− or + | 2 | 1.7 (0.4) | 2.7 (1.2) | 1.3 (1.5) | 1.2 (1.0) |
| BML | 9 | 1.8 (0.7) | 2.9 (0.9) | 2.8 (0.7) | 1.6 (1.0) | |
| B-ML | – | 3 | 1.3 (0.6) | 2.3 (0.6) | 2.3 (1.2) | 2.0 (1.0)#2 |
| B-ML | +/− | 3 | 1.7 (0.6) | 3.0 (1.0) | 3.0 (—) | 1.7 (1.2) |
| B-ML | + | 3 | 2.3 (0.6) | 3.3 (1.2) | 3.0 (—) | 1.0 (1.0) |
TML, T/NK-cell neoplasm; BML, B-cell neoplasm; NKTCL, NK/T-cell lymphoma; Cytotoxic-TML, Cytotoxic T-cell lymphoma; E-NKTCL, Early NK/T-cell lymphoma; EBV+, Complete neoplastic expansion of EBV latent infection (Fig. 1); EBV+/−, Incomplete neoplastic expansion of EBV latent infection (Fig. 1); EBV−, No EBV infection in lymphoma cells (Fig. 1).
Statistical evaluation: Evaluated scores in IHC of each antibody were tested in all combinations of two entities of lymphomas by Mann-Whitney’s U test and in all combinations of more than three entities by Kruskal-Wallis test. In IHC of cathepsin D, only EBV+ NKTCL indicated significantly lower values than cytotoxic TML (#1: Mann-Whitney’s U test, p=0.0387). Significantly lower values were also seen in the order of EBV− BML, cytotoxic TML and EBV+ NKTCL (#2: Kruskal-Wallis test, p=0.0396), in that order.
Fig. 4Immunostaining of beclin-1, LC3, mitochondria (AE-1) and cathepsin D in NKTCL. 1: EBV− NKTCL. 2: EBV+ NKTCL free from degeneration. 3 to 5: EBV+ NKTCL revealing cellular (3), degenerative (4) and necrotic areas (5). a to d: Immunostaining of beclin-1 (a), LC3 (b), AE-1 (c) and cathepsin D (d). The long axis of all the microphotographs was 86 µm long at ×100 magnification. EBV− and EBV+ NKTCL cells in the cellular areas (1–3) showed expression of beclin-1 (a1 and a3), macrogranular staining with background microgranular staining (b1 and b3) or sporadic nuclear stain of LC3 (b2), aggregated mitochondria in many cells (c2 and c3) and expression of cathepsin D in lymphoma cells (d1 and d2). EBV+ NKTCL with degeneration and necrosis showed gradually decreased expression of beclin-1 (a3 to a5), transition from macrogranular (b3 and b4) to nuclear stain of LC3 (b5), aggregated mitochondria labeled by AE-1 (c2, c3 and c4) and reduced expression of Cathepsin D (d3, d4 and d5). These findings indicated a baseline of autophagy with complete degradation of engulfed mitochondria in EBV− NKTCL cells (1), enhanced autophagy with sporadic ACD and highly engulfed mitochondria in EBV+ NKTCL cells in the case free from degeneration (2), and enhanced autophagy with incomplete degradation of engulfed mitochondria ending in regional ACD caused by reduced expression of cathepsin D in EBV+NKTCL cells in the case with degeneration and necrosis (3 to 5).
Fig. 5Immunostaining of beclin-1, LC3, AE-1 and cathepsin D in BML. 1 and 2: EBV− BML with an intraepithelial microabscess (2). 3 and 4: EBV+ BML revealing sporadic tiny necrosis (4). a) Immunostaining of beclin-1. b) Immunostaining of LC3. c) Immunostaining of AE-1. d) Immunostaining of Cathepsin D. The long axis of all the microphotographs was 86 µm long at ×100 magnification. EBV− BML cells showed weak expression of beclin-1 (a1), macrogranular immunostaining of LC3 (b1), aggregated mitochondria (c1) and expression of cathepsin D (d1) when the lymphoma cells in the microabscess revealed little expression of beclin-1 (a2), nucleus-like staining of LC3 (b2), aggregated mitochondria (c2) and no expression of cathepsin D (d2), suggesting a baseline of autophagy in EBV− BML and ACD with incomplete degradation of mitochondria and no expression of cathepsin D in EBV− BML cells in starvation in the microabscess. EBV+ BML cells showed expression of beclin-1 (a3), micro- and macrogranular stain of LC3 (b3), aggregated mitochondria labeled by AE-1 (c3) and no expression of cathepsin D (d3) when some lymphoma cells in a tiny focus of necrosis showed little expression of beclin-1 (a4), some nuclear staining of LC3 in the background of its micro- and macrogranular stain (b4), scant aggregated mitochondria (c4) and no expression of cathepsin D (d4), suggesting enhanced autophagy with incomplete degradation of mitochondria and no expression of cathepsin D in EBV+ BML cells and ending in regional ACD.
Autophagy-related molecules and organella in nasopharyngeal lymphomas in areas with degeneration and necrosis
| Score value or Mean score value (S.D.) of IHC | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beclin-1 | LC3 | Mitochondria (AE-1) | Cathepsin D | |||||||||||||
| n | C | D | N | C | D | N | C | D | N | C | D | N | ||||
| EBV– BML | ||||||||||||||||
| +microabscess | 1 | 1 | 1 | 2 | 4 | 3 | 3 | 3 | 0 | |||||||
| EBV+ BML | 2 | 2.5 (0.7) | 4 (—) | 3 (—) | 1.5 (0.7) | |||||||||||
| +necrosis | 1 | 2 | 1 | 1 | 2 | 2 | 4 | 3 | 1 | 1 | 0 | 0 | 0 | |||
| Cytotoxic-TML | 1* | 2 | 4 | 2 | 2 | |||||||||||
| +necrosis | 2** | 0.5 (0.7) | 0.5 (0.7) | 0 (—) | 2.5 (0.7) | 3 (1.4) | 4.5 (0.7) | 2.0 (1.4) | 2.0 (1.4) | 1 (1.4) | 2 (—) | 1.5 (0.7) | 1.0 (1.4) | |||
| EBV+ NKTCL cellular areas | 4 | 2.0 (1.8) | 3.3 (0.6)#1,3 | 2.0 (0.8)#4 | 1.5 (1.3) | |||||||||||
| +degeneration | 6 | 1.8 (0.8) | 1.3 (0.8) | 3.0 (0.6)#1,2,5 | 4.0 (—)#5 | 2.5 (0.8)#6 | 1.3 (0.8)#6 | 1.2 (0.8) | 0.7 (0.8) | |||||||
| +degeneration and necrosis | 11 | 2.4 (1.1)#7 | 2.1 (1.0)#8 | 0.9 (0.7)#7,8 | 1.9 (0.7)#1,2,3,9,10 | 3.1 (0.8)#9,11 | 4.0 (0.5)#10,11 | 2.8 (0.4)#4,12 | 2.8 (0.4)#13 | 1.4 (0.9)#12,13 | 0.5 (0.7)#14 | 0.5 (0.5) | 0.2 (0.4)#14 | |||
n, Number of cases; C, Cellular area; D, Degenerative area; N, Necrotic area; EBV– BML+microabscess, EBV infection-free BML revealing intraepithelial microabscess; +necrosis, lymphoma revealing foci of necrosis; +degeneration, lymphoma revealing degeneration; +degeneration and necrosis, lymphoma revealing degeneration and necrosis; Cytotoxic-TML 1*, one EBV+/– case; Cytotoxic-TML+necrosis 2**, two EBV+ cases.
Statistical evaluation: NKTCL cells in the cellular area indicated significant gradual decrease in LC-3 score in the groups with cellular, degenerative and necrotic areas (#1: Kruskal-Wallis test, p=0.0036, #2,3: Mann-Whitney’s U test, #2 p=0.0103, #3 p=0.0062) and significant increase of Mitochondria (AE-1) score from the group of cellular area to the group with degenerative and necrotic areas (#4: Mann-Whitney’s U test, p=0.0335). NKTCL cells in the group with degenerative and necrotic areas indicated significant increase in LC3 score (#5: Wilcoxon signed-ranks test, #5 p=0.0339) and significant decrease in Mitochondria (AE-1) score (#6: Wilcoxon signed-ranks test, p=0.0384). NKTCL cells in the group with degenerative and necrotic areas indicated significant decrease of beclin-1 score from groups with the cellular to necrotic areas (#7,8: Wilcoxon signed-ranks test, #7 p=0.0041, #8 p=0.0030), significant increase in LC3 score (#9–11: Wilcoxon signed-ranks test, #9 p=0.0035, #10 p=0.0022, #11 p=0.0041), significant decrease in Mitochondria (AE-1) score (#12,13: Wilcoxon signed-ranks test, #12 p=0.0076, #13 p=0.005) and significant decrease in cathepsin D score (#14: Wilcoxon signed-ranks test, p=0.0455).
Fig. 6Schematic diagram of molecular mechanism of autophagy with synthesis of cathepsin D. Autophagy comprises an initiating stage from Tor to a complex formation that includes Atg1 in the endoplasmic reticulum; a vesicle nucleation stage with a complex including Atg6/beclin-1; vesicle elongation and autophagosome formation stage with membrane-bound LC3 and engulfing target organella; and an auto(phago)lysosome formation stage with activation of lysosome enzymes including cathepsin D. On the other hand, cathepsin D is synthesized in the rough endoplasmic reticulum, develops by adding glyocoproteins to itself in the Golgi apparatus and is stored in the lysosomes when the ATP-dependent H+ pump adds acidity to the lysosome content to activate cathepsin D. Some autolysosomes become endosomes when there is a connection to innate and adaptive immunity, and autolysosomes finally become residual bodies. The pharmacological functional analysis of autophagy is made possible by the inhibition of PI3K sending signals to Tor (the PI3K-Tor pathway) and of the ATP-dependent H+ pump adding acicidity to the lysosomal and autolysosomal contents (the activation of cathepsin D). Each or combined failures in the fusion of autophagosome and lysosome, in the degradation of content in the autolysosome, and in the activation of cathepsin D by ATP-dependent H+ pump induce autophagic cell death (ACD) with enlarged autophagosomes and autolysosomes.